Compagnie Lombard Odier S Cm A Eli Lilly & CO Transaction History

Compagnie Lombard Odier S Cm A

$7.73 Billion
Q1 2025

A detailed history of Compagnie Lombard Odier S Cm A transactions in Eli Lilly & CO stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 220,861 shares of LLY stock, worth $183 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares

220,861

Previous 127,649 73.02%

Holding current value

$183 Million

Previous $98.5 Million 85.1%

% of portfolio

2.36%

Previous 1.54%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$725.72 - $929.72 $67.6 Million - $86.7 Million	93,212 Added 73.02%	220,861 $182 Million
Q4 2024 Jan 30, 2025	BUY	$727.2 - $932.06 $40.9 Million - $52.5 Million	56,285 Added 78.87%	127,649 $98.5 Million
Q3 2024 Oct 11, 2024	BUY	$772.14 - $960.02 $4.25 Million - $5.28 Million	5,498 Added 8.35%	71,364 $63.2 Million
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $7.27 Million - $9.12 Million	10,031 Added 17.97%	65,866 $59.6 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $8.63 Million - $11.5 Million	14,574 Added 35.32%	55,835 $43.4 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $12.5 Million - $14.8 Million	23,883 Added 137.43%	41,261 $24.1 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $4.84 Million - $6.67 Million	11,134 Added 178.32%	17,378 $9.33 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $1.04 Million - $1.39 Million	2,958 Added 90.02%	6,244 $2.93 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $500,424 - $587,725	1,611 Added 96.18%	3,286 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $255,632 - $297,862	795 Added 90.34%	1,675 $612,000
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $147,054 - $167,583	-496 Reduced 36.05%	880 $284,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $100,342 - $117,817	360 Added 35.43%	1,376 $446,000
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $44,356 - $55,123	-189 Reduced 15.68%	1,016 $291,000
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $67,455 - $83,712	300 Added 33.15%	1,205 $333,000
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $139,672 - $180,812	-850 Reduced 48.43%	905 $169,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $228,957 - $302,965	1,755 New	1,755 $296,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $0 - $0	0 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $48,220 - $59,725	-451 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $48,162 - $52,388	451 New	451 $50,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $88,632 - $103,456	-800 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $33,485 - $41,850	390 Added 95.12%	800 $86,000
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $114,797 - $123,133	-1,401 Reduced 77.36%	410 $35,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,811	1,811 $149,000

Others Institutions Holding LLY

# of Institutions

4,324

Shares Held

758M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $786B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Eli Lilly & CO Transaction History